Multiple initiatives to conquer KRAS G12C inhibitor resistance from the perspective of clinical therapy
Sign Up to like & getrecommendations! Published in 2023 at "Expert Opinion on Investigational Drugs"
DOI: 10.1080/13543784.2023.2178419
Abstract: ABSTRACT Introduction KRAS G12C targeted covalent inhibitors for cancer therapy are revolutionary. However, resistance to KRAS G12C inhibitors in clinical trials is a proven fact. Areas covered The authors focus on providing coverage and emphasizing… read more here.
Keywords: kras g12c; inhibitor resistance; therapy; resistance ... See more keywords